Encube to acquire Soframycin in India, Sri Lanka for Rs 125 cr
Encube Ethicals announced that it will be acquiring the skin cream and associated brands for the Indian and Sri Lankan market for a consideration of Rs 125 crore.
Encube Ethicals has agreed to enter into definitive agreements with Sanofi group for acquiring Soframycin. Pic: Twitter handle of Sanofi US and https://www.encubeethicals.com/